Handelsbanken Fonder’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,851
Closed -$772K 1501
2025
Q2
$772K Hold
7,851
﹤0.01% 1063
2025
Q1
$727K Hold
7,851
﹤0.01% 1078
2024
Q4
$713K Buy
7,851
+1,600
+26% +$147K ﹤0.01% 1145
2024
Q3
$603K Hold
6,251
﹤0.01% 1167
2024
Q2
$574K Hold
6,251
﹤0.01% 1094
2024
Q1
$576K Hold
6,251
﹤0.01% 1098
2023
Q4
$594K Sell
6,251
-97,800
-94% -$9.13M ﹤0.01% 1065
2023
Q3
$9.72M Hold
104,051
0.05% 321
2023
Q2
$9.51M Buy
104,051
+15,000
+17% +$1.23M 0.05% 342
2023
Q1
$6.55M Hold
89,051
0.04% 378
2022
Q4
$7.44M Buy
89,051
+17,500
+24% +$1.58M 0.05% 366
2022
Q3
$6.92M Buy
71,551
+67,500
+1,666% +$8.05M 0.05% 351
2022
Q2
$426K Hold
4,051
﹤0.01% 1116
2022
Q1
$698K Sell
4,051
-2,200
-35% -$329K ﹤0.01% 973
2021
Q4
$1.01M Sell
6,251
-300
-5% -$48.2K 0.01% 884
2021
Q3
$977K Buy
6,551
+1,300
+25% +$270K 0.01% 921
2021
Q2
$1.29M Sell
5,251
-300
-5% -$78.7K 0.01% 789
2021
Q1
$1.47M Hold
5,551
0.01% 688
2020
Q4
$1.63M Hold
5,551
0.01% 652
2020
Q3
$1.31M Hold
5,551
0.01% 643
2020
Q2
$1.1M Buy
+5,551
New +$1.04M 0.01% 657

Other funds holding AMED

Handelsbanken Fonder's AMED Position: Q3 2025 in Review

Handelsbanken Fonder sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,851 shares — an estimated $772K sold.

Handelsbanken Fonder first reported a position in AMED in Q2 2020 and held it in 21 quarters. The position peaked at $9.72M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Handelsbanken Fonder reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 7,851 Amedisys shares in Q3 2025, an estimated $772K.
  • Handelsbanken Fonder first reported a position in Amedisys in Q2 2020 and held it in 21 quarters.
  • Handelsbanken Fonder's Amedisys position peaked at $9.72M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Handelsbanken Fonder's 13F filing for Q3 2025, filed 12 Nov 2025.